|
Issue |
Title |
|
No 2 (2020) |
Effectiveness of the surgery in tuberculosis patients at the hospital stage of treatment in the city of Moscow |
Abstract
PDF (Rus)
|
M. V. Sinitsin, E. M. Belilovsky, A. A. Vorobiev, S. E. Borisov, M. V. Matveeva |
|
No 2 (2020) |
Adverse events of the new and traditional chemotherapy regimens in the patients with multi drug resistant pulmonary tuberculosis |
Abstract
PDF (Rus)
|
O. V. Rodina, S. E. Borisov, D. A. Ivanova |
|
No 3 (2020) |
Immunological methods for tuberculosis treatment effectiveness evaluation in children |
Abstract
PDF (Rus)
|
N. A. Barmina, Yu. V. Korneev, T. I. Danilova |
|
No 4 (2019) |
Cohort analysis of the effectiveness of the new and traditional regimens for tuberculosis patients’ chemotherapy |
Abstract
PDF (Rus)
|
A. V. Filippov, S. E. Borisov, E. M. Belilovsky, I. D. Danilova |
|
No 4 (2019) |
CLINICAL EFFICIENCY OF APPLICATION OF MEDICINES CONTAINING GLYCIRRIZIN ACID IN PATIENTS WITH LUNG TUBERCULOSIS |
Abstract
PDF (Rus)
|
D. S. Riasenskii, A. V. Aseev, N. A. Grishkina |
|
No 2 (2020) |
Experience of department of reanimatology and intensive care for children in Moscow city research and clinical center for tuberculosis control (2000–2020 years) |
Abstract
PDF (Rus)
|
I. V. Shirshov, D. V. Leontiev, S. V. Burkin, E. P. Torlopov, E. V. Mikhailov, |
|
No 2 (2019) |
The role of laboratory examination of surgical material by different methods in determining the regimen of antituberculosis therapy |
Abstract
PDF (Rus)
|
E. V. Nekrasov, V. N. Trusov, T. K. Tokaev, G. I. Semenov, D. A. Ivanova, M. M. Zhuravleva |
|
No 2 (2019) |
Maintenance therapy by functional nutrition in pulmonary tuberculosis patients |
Abstract
PDF (Rus)
|
E. V. Savintseva, O. Е. Russkikh, A. R. Gainutdinova |
|
No 1 (2019) |
Complex surgical treatment of patients with widespread destructive pulmonary tuberculosis with multiple drug resistance of mycobacteria using intravenous immunoglobulin Pentaglobin |
Abstract
PDF (Rus)
|
S. N. Penagi, M. A. Bagirov, G. N. Mozhokina, E. V. Krasnikova, R. N. Penagi |
|
No 1 (2019) |
Evaluation of the treatment adherence in TB-patients: experience of the graduated scale in the in-patient clinic |
Abstract
PDF (Rus)
|
A. V. Filippov, I. N. Melnikova, S. A. Kosenkov, E. P. Kubrakova, A. I. Titomer, A. I. Kazakov |
|
No 4 (2018) |
Tuberculosis treatment – from the point of view of pharmacology and pharmacotherapy Part 2 |
Abstract
PDF (Rus)
|
N. M. Krasnova, A. F. Kravchenko, N. S. Val’ |
|
No 4 (2018) |
Adverse reactions in the TB treatment of children |
Abstract
PDF (Rus)
|
G. V. Klimov, N. G. Ershova, E. V. Bogdanova |
|
No 1 (2018) |
THE EFFECTIVENESS OF ADEMETIONINE WHEN THE DRUG TO LIVER DAMAGE ON THE BACKGROUND OF ANTI-TB CHEMOTHERAPY |
Abstract
PDF (Rus)
|
D. A. Ivanova, S. E. Borisov, N. Yu. Nikolenko |
|
No 2 (2018) |
NOWADAY INDICACIONS TO SURGERY FOR LUNG TUBERCULEMAS |
Abstract
PDF (Rus)
|
M. A. Bagirov, L. N. Lepeha, S. S. Sadovnikova, N. L. Karpina, E. V. Krasnikova, M. V. Erokhina |
|
No 3 (2018) |
Tuberculosis treatment – from the point of view of pharmacology and pharmacotherapy |
Abstract
PDF (Rus)
|
N. M. Krasnova, A. F. Kravchenko, N. S. Val’ |
|
No 3 (2018) |
RISK OF THE HEPATOTOXICITY EVALUATION BY THE PHARMACOGENETIC METHODS IN NEW TUBERCULOSIS PATIENTS |
Abstract
PDF (Rus)
|
D. A. Ivanova, X. Yu. Galkina, S. E. Borisov, S. G. Safonova, D. A. Kudlai |
|
No 3 (2017) |
Hyperuricemia during anti-tuberculosis therapy: clinical significance, risk factors and monitoring strategies |
Abstract
PDF (Rus)
|
D. A. Ivanova, S. E. Borisov, A. M. Ryzhov |
|
No 3 (2017) |
Endoscopic procedures in tuberculosis patients with pulmonary blee ding in in-patient clinic |
Abstract
PDF (Rus)
|
M. V. Matrosov, B. D. Svistunov, A. S. Svistunova, T. V. Udivanova |
|
No 4 (2017) |
Effect of silymarin for the prevention of drug-induced liver injury in tuberculosis patients |
Abstract
PDF (Rus)
|
D. A. Ivanova, , S. E. Borisov, |
|
No 3 (2016) |
New opportunities in treatment of pulmonary tuberculosis with extensively drug resistance treatment |
Abstract
PDF (Rus)
|
E. N. Belyaeva, T. Yu. Suprun, T. B. Potepun, M. V. Pavlova, N. V. Sapozhnikova, I. V. Chernohaeva, A. A. Starshinova |
|
No 4 (2016) |
Pneumonectomy in tuberculosis patients– results, complications and their treatment |
Abstract
PDF (Rus)
|
K. A. Bogdanov, G. V. Didenko |
|
No 5 (2016) |
Experience of the routine third-line antituberculosis drugs administration |
Abstract
PDF (Rus)
|
D. L. Isikov, N. V. Antonova, O. B. Sergienko, S. V. Lazebny, I. A. Lapyreva |
|
No 5 (2016) |
Osteoplastic thoracomyoplastics as a variant of surgical treatment of the post-pneumonectomes empyema, when it is possible to preserve the shell of thorax |
Abstract
PDF (Rus)
|
V. N. Trusov, E. V. Nekrasov, D. R. Faysullin, G. I. Semenov |
|
No 1 (2017) |
Витамин В6 и его применение во фтизиатрии |
Abstract
PDF (Rus)
|
, , |
|
No 3 (2016) |
Some aspects of the drug-susceptible tuberculosis treatment |
Abstract
PDF (Rus)
|
T. I. Morozova, N. P. Doctorova |
|
Vol 12, No 3 (2024) |
Analysis of treatment in newly diagnosed patients according to drug-sensitive tuberculosis regimen |
Abstract
PDF (Rus)
|
M. V. Uraksina, E. P. Eremenko, E. A. Borodulina, B. E. Borodulin |
|
Vol 12, No 3 (2024) |
The effectiveness of surgical treatment of patients with lung cancer in combination with active tuberculosis |
Abstract
PDF (Rus)
|
E. V. Nekrasov, M. V. Sinitsyn, A. A. Vorobyov, D. A. Ivanova |
|
Vol 12, No 3 (2024) |
Risk factors for postoperative complications and tuberculosis relapses: a retrospective study |
Abstract
PDF (Rus)
|
D. B. Giller, A. N. Ilyukhin, Sh. E. Mayusupov, S. S. Saenko, G. V. Shcherbakova, O. Sh. Kesaev |
|
Vol 12, No 3 (2024) |
Effect of the enhanced recovery after surgery (ERAS) protocol on the outcome of augmentation ileocystoplasty due to microcystis of tuberculous and other origin |
Abstract
PDF (Rus)
|
O. N. Zuban, M. A. Prokopovich, R. M. Chotchaev, D. A. Vishnevsky, M. P. Korchagin |
|
Vol 11, No 4 (2023) |
The effectiveness of chemotherapy regimens with the inclusion of linezolid in children and teenagers with tuberculosis |
Abstract
PDF (Rus)
|
E. D. Zubova, E. R. Tokhtakhodzhaeva, O. K. Kiselyevich, A. N. Yusubova |
|
Vol 11, No 3 (2023) |
Risk factors for cardiotoxic adverse reactions in the treatment of tuberculosis patients with MDR and XDR of the pathogen |
Abstract
PDF (Rus)
|
D. A. Ivanova, O. V. Rodina, N. V. Litvinova, S. E. Borisov, Yu. Yu. Mitrofanova |
|
Vol 11, No 1 (2023) |
Evaluation of the empirical approach in the selection of pathogenetic agents in the treatment of pulmonary tuberculosis (on the example of drugs Glutoxim and Tubosan) |
Abstract
PDF (Rus)
|
T. N. Kondakova, R. G. Kovaleva, A. V. Elkin, K. G. Tyarasova, S. M. Khorkova |
|
Vol 9, No 4 (2021) |
Cost of the Adverse Events of the Various Chemotherapy Regimens for the Multidrug Resistant Tuberculosis |
Abstract
PDF (Rus)
|
O. V. Rodina, N. Yu. Nikolenko, D. A. Ivanova, S. E. Borisov, O. V. Krivtsova, D. A. Kudlay |
|
Vol 9, No 4 (2021) |
The Effectiveness and the Safety of Combined Tuberculosis Treatment Regimens Using the Drug Perchlozon. Methods of Forecasting, Prevention and Elimination of Adverse Events |
Abstract
PDF (Rus)
|
E. S. Ershova, A. L. Turik, M. V. Pavlova, E. A. Revjakin |
|
Vol 9, No 4 (2021) |
The Effectiveness of Treatment of Pulmonary Tuberculosis in Combination with HIV Infection in a Civilian TB Institution by Gender |
Abstract
PDF (Rus)
|
E. M. Condratenko, V. S. Borovitsky, R. V. Makarov |
|
Vol 9, No 4 (2021) |
The Effectiveness of Autologous Composition Based on Dendritic Cells in the Treatment of Pulmonary Tuberculosis with Extremely Drug Resistance After an Ineffective Course of Polychemotherapy |
Abstract
PDF (Rus)
|
M. V. Filatov, A. A. Starshinova, M. M. Nazarenko, Yu. S. Zinchenko, E. V. Istomina, E. N. Belaeva, S. B. Landa, V. V. Burdakov, M. V. Pavlova, P. K. Yablonskiy |
|
Vol 9, No 3 (2021) |
Remote support of treatment of a patient with tuberculosis with the help of a self-monitoring |
Abstract
PDF (Rus)
|
E. A. Kotova,, E. M. Bogorodskaya, N. N. Istomina |
|
Vol 9, No 3 (2021) |
Tuberculosis behind bars or the disease is not a sentence. Clinical experience of using the drug Perchlozon® in patients with tuberculosis with multy- and extended drug resistance in the moscow penitenciary |
Abstract
PDF (Rus)
|
S. S. Shilovsky |
|
Vol 9, No 1 (2021) |
The possibility of questioning of tuberculosis patients in the control of unwanted side reactions |
Abstract
PDF (Rus)
|
A. A. Shmakova, A. G. Smetanin, E. A. Smetanina |
|
Vol 9, No 1 (2021) |
Adverse events in children and adolescents in tuberculosis chemotherapy with second- and third-line drugs |
Abstract
PDF (Rus)
|
E. D. Zubova, G. R. Tathodzhaeva, O. Yu. Sentchihina, O. K. Kiselevitch, A. N. Yusubova, E. E. Vlasova |
|
1 - 40 of 40 Items |
|